Details for New Drug Application (NDA): 017959
✉ Email this page to a colleague
NDA 017959 describes ADRUCIL, which is a drug marketed by Pharmacia And Upjohn and Teva Parenteral and is included in four NDAs. Additional details are available on the ADRUCIL profile page.
The generic ingredient in ADRUCIL is fluorouracil. There are fifteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the fluorouracil profile page.
The generic ingredient in ADRUCIL is fluorouracil. There are fifteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the fluorouracil profile page.
Summary for 017959
| Tradename: | ADRUCIL |
| Applicant: | Pharmacia And Upjohn |
| Ingredient: | fluorouracil |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017959
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
